DNDi Mulls Expansion Of India Site; Set To Team With More Pharma On The Heels Of Sanofi Deal - BIO Conference
This article was originally published in PharmAsia News
WASHINGTON - Six years after establishing its India office, Geneva-based Drugs for Neglected Diseases Initiative (DNDi) is planning to expand its presence to cater to the drug development needs of the Indian population as well as neighboring countries like Bangladesh and Sri Lanka
You may also be interested in...
Indian Lobby Groups Laud Global Efforts To Eliminate NTDs But Call For Stronger Grassroots Delivery Mechanism
India lobby groups question whether global efforts to eliminate neglected tropical diseases will provide concrete local solutions, noting that drugs are just a part of the problem.
Pharma Joins Forces With WHO, Global Governments In Unprecedented Effort To Control Neglected Tropical Diseases
Big Pharma join hands with WHO, global governments and foundations in unprecedented effort to wipe out neglected tropical diseases.
Emerging Markets Sanofi's "Most Important" Segment; Merck Looks To "Win" China: Emerging Markets Earnings Round Up (Part 1)
Emerging markets continue to figure prominently in Big Pharma strategies for commanding growth, with China being the top priority.